TrialDiabetes technology & therapeutics2017

Efficacy and Safety of Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in High-Risk and Low-Risk Patients with Type 2 Diabetes Stratified Using Common Clinical Performance Measures.

Ildiko Lingvay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.